Generation Bio Financials
| GBIO Stock | USD 0.68 0.06 9.68% |
Generation |
Understanding current and past Generation Bio Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Generation Bio's financial statements are interrelated, with each one affecting the others. For example, an increase in Generation Bio's assets may result in an increase in income on the income statement.
Generation Bio Stock Summary
Generation Bio competes with Monte Rosa, Nkarta, Lyell Immunopharma, Sana Biotechnology, and Kronos Bio. Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. Generation Bio Co. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts. Generation Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 150 people.Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| ISIN | US37148K1007 |
| CUSIP | 37148K100 |
| Location | Massachusetts; U.S.A |
| Business Address | 301 Binney Street, |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | generationbio.com |
| Phone | 617 655 7500 |
| Currency | USD - US Dollar |
Generation Bio Key Financial Ratios
Generation Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Generation Bio's current stock value. Our valuation model uses many indicators to compare Generation Bio value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Generation Bio competition to find correlations between indicators driving Generation Bio's intrinsic value. More Info.Generation Bio Co is rated below average in return on equity category among its peers. It is rated # 4 in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Generation Bio's earnings, one of the primary drivers of an investment's value.Generation Bio Systematic Risk
Generation Bio's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Generation Bio volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty-one with a total number of output elements of fourty. The Beta measures systematic risk based on how returns on Generation Bio correlated with the market. If Beta is less than 0 Generation Bio generally moves in the opposite direction as compared to the market. If Generation Bio Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Generation Bio is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Generation Bio is generally in the same direction as the market. If Beta > 1 Generation Bio moves generally in the same direction as, but more than the movement of the benchmark.
Generation Bio February 17, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Generation Bio help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Generation Bio Co. We use our internally-developed statistical techniques to arrive at the intrinsic value of Generation Bio Co based on widely used predictive technical indicators. In general, we focus on analyzing Generation Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Generation Bio's daily price indicators and compare them against related drivers.
| Information Ratio | (0.23) | |||
| Maximum Drawdown | 22.69 | |||
| Value At Risk | (7.89) | |||
| Potential Upside | 6.41 |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Generation Bio Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Generation Bio. If investors know Generation will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Generation Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Generation Bio is measured differently than its book value, which is the value of Generation that is recorded on the company's balance sheet. Investors also form their own opinion of Generation Bio's value that differs from its market value or its book value, called intrinsic value, which is Generation Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Generation Bio's market value can be influenced by many factors that don't directly affect Generation Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Generation Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Generation Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Generation Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.